Brief: FDA Approved Merck's BLA For Pneumococcal 21-Valent Conjugate Vaccine Effective July 17
17/06/2024 23:36
June 17 (Reuters) - Ligand Pharmaceuticals Inc LGND.O :
* FDA: APPROVED MERCK'S BLA FOR PNEUMOCOCCAL 21-VALENT
CONJUGATE
VACCINE EFFECTIVE JULY 17
Further company coverage: LGND.O
Recent news on Ligand Pharmaceuticals Incorporated
See all newsBrief: Ligand Acquires Royalty And Milestone Interest In Santen’s Ryjunea From Sydnexis For $23 Million
Ligand Pharmaceuticals Incorporated reports results for the quarter ended June 30 - Earnings Summary
Ligand Pharmaceuticals Q2 revenue rises on royalty growth
Brief: Ligand Pharmaceuticals Q2 EPS USD 2.22
U.S. RESEARCH ROUNDUP-Equinix, Goldman Sachs, JPMorgan